AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

FENNEC PHARMACEUTICALS INC. Director's Dealing 2007

Dec 5, 2007

35599_dirs_2007-12-05_4ae100db-49cb-4bb5-b1f4-718f91d2e61c.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ADHEREX TECHNOLOGIES INC (AMEX:ADH)
CIK: 0001211583
Period of Report: 2007-12-03

Reporting Person: KUFE DONALD W (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2007-12-03	Stock Options (Right to buy)	$0.28	A	75000	Acquired	2014-12-03	Common Stock (75000)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (Right to buy)	$0.28	2014-02-28	Common Stock (50000)	50000	Direct
Stock Options (Right to buy)	$0.63	2014-04-30	Common Stock (170000)	170000	Direct
Stock Options (Right to buy)	$0.88	2012-12-14	Common Stock (2500)	2500	Direct
Stock Options (Right to buy)	$1.2	2012-09-21	Common Stock (40000)	40000	Direct
Stock Options (Right to buy)	$1.2	2012-05-18	Common Stock (19621)	19621	Direct
Stock Options (Right to buy)	$1.7	2010-05-03	Common Stock (4000)	4000	Direct
Stock Options (Right to buy)	$2.9	2011-05-21	Common Stock (4000)	4000	Direct
Stock Options (Right to buy)	$3.25	2011-03-01	Common Stock (19621)	19621	Direct

Footnotes

F1: The options to which this note relates will vest 100% on the date reported above.